HSPG2 and acute myeloid leukemia: We found that the expression of these stage-specific SFs associated with PLCs, but not those associated with normal cells, had prognostic value in human AML patients, and the prognostic value of PLC SFs progressively increased from T1 to T3 (Fig 2E).